Neovasc Inc. Capex per Share

Capex per Share of NVCN for past 10 years: annual, quarterly and twelve month trailing (TTM) including Capex per Share growth rates and interactive chart. Capex per share refers to the total amount of capital expenditures paid in a period divided by the weighted average number of shares outstanding. If a company has capex of $100 million and 10 million shares outstanding, capex per share is $10.


Highlights and Quick Summary

  • Capex per Share for the quarter ending March 31, 2022 was 0.0 (a -100.0% decrease compared to previous quarter)
  • Year-over-year quarterly Capex per Share decreased by -100.0%
  • Annual Capex per Share for 2021 was -0.07 (a -87.3% decrease from previous year)
  • Annual Capex per Share for 2020 was -0.51 (a -45.15% decrease from previous year)
  • Annual Capex per Share for 2019 was -0.93 (a -107.84% decrease from previous year)
  • Twelve month Capex per Share ending March 31, 2022 was 0.0 (a -100.0% decrease compared to previous quarter)
  • Twelve month trailing Capex per Share decreased by -100.0% year-over-year
Trailing Capex per Share for the last four month:
31 Mar '22 31 Dec '21 30 Sep '21 30 Jun '21
0.0 -0.06 -0.08 -0.16
Visit stockrow.com/NVCN for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Capex per Share of Neovasc Inc.

Most recent Capex per Shareof NVCN including historical data for past 10 years.

Interactive Chart of Capex per Share of Neovasc Inc.

Neovasc Inc. Capex per Share for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 0.0
2021 -0.01 0.0 -0.04 -0.02 -0.07
2020 -0.07 -0.28 -0.01 -0.09 -0.51
2019 -0.31 -0.19 -0.23 -0.28 -0.93
2018 -0.47 -1.63 15.92 -0.05 11.93
2017 -18.12 -17.38 -35.97 -88.77 -153.24
2016 25049.0 -5.63 -83.67 -113.19 24846.52
2015 -177.78 -145.52 -323.04 -157.96 -824.27
2014 -263.64 -118.18 -109.09 -26.32 -533.48
2013 -26.32 -47.37 -294.74 -172.22 -531.58
2012 -42.11 -22.22 -55.56 -50.0 -172.22
2011 -94.12 -94.12

Business Profile of Neovasc Inc.

Sector: Healthcare
Industry: Medical Devices
Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.